Seattle Genetics | SGEN - Current Liabilities


Seattle Genetics reported $954.72M in Current Liabilities for its fiscal quarter ending in September of 2023.



Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Agios Pharmaceuticals USD 82.21M 7.45M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Astellas Pharma JPY 1.32T 873M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Celldex Therapeutics USD 50.99M 4.53M Dec/2025
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Eisai JPY 387.67B 9.42B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Esperion Therapeutics USD 300.81M 58.22M Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Genmab DKK 1.43B 686M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Glaxosmithkline GBP 28.82B 144.79M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Insmed USD 468.87M 51.66M Dec/2025
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
MacroGenics USD 43.11M 1.36M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Moderna USD 1.99B 306M Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Puma Biotechnology USD 82.73M 3.63M Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Sarepta Therapeutics USD 1.1B 173.86M Dec/2025
Takeda JPY 2.61T 470.53B Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025
Xencor USD 95.91M 9.42M Dec/2025